Rodwige J. Desnoyers

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

Tanios Bekaii‐Saab, Fang‐Shu Ou, Daniel H. Ahn et al. · The Lancet Oncology · 2019 · 284 citations · Full text

Medicine, Oncology, Pharmacology +12

DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides

Peter J. Smith, Nicola Blunt, Rodwige J. Desnoyers et al. · Cancer Chemotherapy and Pharmacology · 1997 · 74 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Ectopic Expression of Guanylyl Cyclase C in CD34⁺ Progenitor Cells in Peripheral Blood

Tracy A. Fava, Rodwige J. Desnoyers, Stephanie Schulz et al. · Journal of Clinical Oncology · 2001 · 45 citations

Medicine, Molecular Biology, Oncology +17

Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center

Ville Kytölä, Ümit Topaloĝlu, Lance D. Miller et al. · Theranostics · 2017 · 41 citations · Full text

Life Sciences, Genetics, Oncology +17

First metatarsocuneiform joint arthrodesis: a five-year retrospective analysis.

G M Saffo, M F Wooster, Martin Stevens et al. · PubMed · 1989 · 41 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16